Duloxetine Pellet Separating Layer Prevents Ionic Interaction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmaceutical formulations, particularly those containing duloxetine hydrochloride, face challenges in achieving complete release and gastric juice resistance due to interactions between cationic active ingredients and anionic polymers, leading to incomplete dissolution and potential toxicity in acidic environments.
Innovation Solution
A pharmaceutical preparation in pellet form with a core containing duloxetine hydrochloride, a separating layer of an ester of optionally substituted cellulose with organic acids, and an enteric layer comprising a (meth)acrylic acid-containing polymer, along with an inner protective layer of sugar, is developed to prevent interactions and ensure complete release in the digestive tract.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If an enteric layer comprising anionic polymers is used to achieve gastric juice resistance, then protection from stomach acid is improved, but interactions with cationic active ingredients lead to incomplete dissolution
Solution Approach 1:
A separating layer comprising a polymer with both carboxyl and hydroxyl groups is introduced between the enteric layer (anionic polymer) and the active ingredient (cationic compound). This intermediary layer prevents direct interaction between the anionic and cationic components, eliminating the formation of insoluble complexes while maintaining the enteric coating's gastric juice resistance. The separating layer acts as a buffer that avoids both ionic cross-linking and hydrogen bonding that would otherwise occur.
Solution Approach 2:
The coating system is divided into distinct functional layers: an enteric layer for gastric juice resistance, a separating layer to prevent interactions, and an active ingredient core. This segmentation allows each layer to perform its specific function independently, with the separating layer specifically designed to block harmful interactions between the enteric polymer and the cationic active ingredient.
2Object-affected harmful factors
If conventional separating layers are used to prevent interactions, then direct contact between active ingredients and enteric polymers is reduced, but incomplete release and potential toxicity remain in acidic environments
Solution Approach 1:
The separating layer polymer is specifically selected to have dual functionality with both carboxyl and hydroxyl groups, creating a unique chemical parameter profile that differs from conventional separating layers. This dual-group polymer maintains pH-dependent solubility characteristics while preventing ionic interactions, ensuring complete drug release across different pH conditions including acidic environments.
3Stability of the object's composition
If enteric-coated formulations are used to protect acid-labile active ingredients, then stability in stomach acid is improved, but incomplete dissolution occurs due to ionic interactions
Solution Approach 1:
The separating layer serves as a mediator that preserves the enteric coating's acid stability function while preventing the ionic interaction that causes dissolution problems. The carboxyl-hydroxyl polymer in the separating layer blocks the electrostatic attraction between the anionic enteric polymer and cationic active ingredient, allowing the enteric layer to maintain its protective function without compromising dissolution.
Data Source
Figure 1
Figure 2
AI summary
The invention relates to a granular pharmaceutical preparation comprising a core containing an active substance, comprising duloxetine or a pharmaceutically acceptable salt thereof, an optional first separating layer over the core, a second separating layer over the first separating layer, said second separating layer being different from the first separating layer and comprising an ester made of optionally substituted cellulose with one or more organic acids, and an enteric-coated layer, which is different from the first and the second separating layers and comprises a (meth)acrylic acid-containing polymer and forms the outer layer of the composition.